Xenon Pharmaceuticals Inc (XENE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	7.50	-
Operating Expenses	13.94% 109.77	96.34	94.23	80.24	73.68
Benefits Costs and Expenses	16.08% 104.72	90.22	85.33	72.12	-
Costs And Expenses	16.08% 104.72	90.22	85.33	72.12	-
Depreciation and Amortization	4.68% 0.611	0.641	0.632	0.659	0.669
Operating Income/Loss	13.94% -109.77	-96.34	-94.23	-72.74	-73.68
Nonoperating Income/Loss	17.54% 5.044	6.117	8.897	8.118	10.57
Income/Loss From Continuing Operations Before Tax	16.08% -104.72	-90.22	-85.33	-64.62	-63.11
Income Tax Expense/Benefit, Deferred	58.92% -1.114	-0.701	-0.17	-1.213	-0.322
Income Tax Expense/Benefit	20.53% 0.538	0.677	-0.626	0.427	-0.32
Income/Loss From Continuing Operations After Tax	15.80% -105.26	-90.90	-84.71	-65.05	-62.79
Net Income/Loss	15.80% -105.26	-90.90	-84.71	-65.05	-62.79
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.63% 0.2908	79.25	78.95	78.69	77.93
Diluted Average Shares	99.63% 0.2908	79.25	78.95	78.69	77.93
Basic Earnings Per Share	13.91% -1.31	-1.15	-1.07	-0.83	-0.81
Diluted Earnings Per Share	13.91% -1.31	-1.15	-1.07	-0.83	-0.81
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%